Status:
COMPLETED
Smartphone App-assisted PPI
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Heartburn
Dyspepsia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Proton pump inhibitors (PPIs) are frequently prescribed for 30 days but taken infinitely. PPIs belong to the most often inappropriate medicines (PIMs). Correct intake of medicines (named adherence) ca...
Detailed Description
This is an exploratory study in a primary care setting with community pharmacists recruiting patients who are newly prescribed a PPI for a short-term treatment (30 days). There is no control group and...
Eligibility Criteria
Inclusion
- is ≥18 years old;
- has symptoms that suggest or correspond to gastroesophageal reflux disease (GERD);
- is newly prescribed a short-term PPI treatment;
- accepts to use of the smartphone app mednet during the study period;
- signs the informed consent form;
- understands and speaks (Swiss) German.
Exclusion
- in the opinion of the pharmacist or physician, unlikely to comply with the study schedule or are unsuitable for any other reason.
Key Trial Info
Start Date :
September 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06094062
Start Date
September 5 2023
End Date
January 15 2025
Last Update
February 13 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Goldene Engel Apotheke
Basel, Canton of Basel-City, Switzerland, 4001
2
TopPharm Apotheke am Spalebärg
Basel, Canton of Basel-City, Switzerland, 4051